Pharmafile Logo
Pharmafocus logo
Advanced Search
Scotland flag

Three new drugs approved for use in Scotland

November 12, 2015
Sales and Marketing Scottish Medicines Consortium

The Scottish Medicines Consortium (SMC) has given the go-ahead for the use of several drugs on the NHS in Scotland. …

News
Benlysta

GSK ready for lupus drug push

November 12, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …

News
new Merck sign

Merck achieves 7% sales growth in Q3 2015

November 12, 2015
Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …

News
MSF poster

MSF launches global action against GSK and Pfizer over pneumonia vaccine price

November 12, 2015
Manufacturing and Production, Sales and Marketing Doctors Without Borders, GSK, MSF, Médecins Sans Frontières, Pfizer, Synflorix, pneumococcal vaccine, pneumonia, prevenar 13, vaccines

International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the …

News
LEO logo

LEO Pharma buys dermatology portfolio from Astellas

November 12, 2015
Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers

LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …

News

Astellas to acquire Ocata Therapeutics in $379m buyout

November 11, 2015
Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …

News
roche

FDA approves Roche skin cancer combination

November 11, 2015
Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …

News
ABPI

UK ‘lacks the skills’ for future drug development, ABPI warns

November 11, 2015
Business Services, Research and Development ABPI, Jobs, careers, recruitment, skills gap

A shortage of skilled professionals threatens to undermine research and development of new medicines in the UK and prevent growth …

News
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015
Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

News

Lilly/Incyte RA drug bests Humira in Phase III trial

November 10, 2015
Research and Development Humira, baricitinib, lilly, phase III, rheumatoid arthritis

Eli Lilly says its investigational therapy baricitinib outperformed AbbVie’s Humira after 12 weeks in a late-stage study of people with …

News
ABPI

ABPI welcomes science budget inquiry findings

November 10, 2015
Manufacturing and Production, Research and Development ABPI, Comprehensive Spending Review

The UK pharma trade body, the ABPI, has welcomed the findings of the Science and Technology Committee’s inquiry into the …

News
Westminster

All Party Parliamentary Group for Life Sciences CSR letter to the Chancellor, Business Secretary and Science Ministers

November 10, 2015
Manufacturing and Production, Research and Development Chancellor, Comprehensive Spending Review, George Osborne

Dear Mr Osborne,Ahead of the forthcoming Comprehensive Spending Review I am sure you will have received many letters from across …

Feature
Janssen image

Janssen buys licence to diabetes and obesity drugs from Hanmi

November 10, 2015
Manufacturing and Production, Research and Development Janssen, diabetes, hanmi

Janssen could spend up to a billion dollars to buy for novel clinical stage biologics to treat diabetes and obesity. …

News

FDA warnings create woe for Indian drugmakers

November 10, 2015
Manufacturing and Production CGMP, Dr Reddy's, Dr. Reddy's, FDA, India, Sun Pharma, manufacturing, production

Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …

News
flu vaccine

Sanofi Pasteur ‘actively exploring’ universal flu vaccine

November 10, 2015
Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine

Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …

News

Jardiance scores more cardiovascular outcomes data

November 10, 2015
Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes

A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …

News

Health minister criticised for blocking Off-Patent Drugs Bill debate

November 9, 2015
Research and Development, Sales and Marketing Alistair Burt, Breast Cancer Now, MS Society, Off-Patent Drugs Bill

A Parliamentary Bill backing the wider use of off-patent drugs has been kicked into the long grass after the Government …

News
EMA HQ

EMA concludes HPV vaccines do not cause CRPS or POTS

November 9, 2015
Sales and Marketing EMA, HPV, HPV vaccine, PRAC, complex regional pain syndrome, drug safety, postural orthostatic tachycardia syndrome

The European Medicines Agency says there is no evidence from a detailed scientific review of reports linking complex regional pain …

News
UNITAID

Medicines Patent Pool to include hep C and TB drugs

November 9, 2015
Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis

The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …

News
clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015
Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026